As a supplier who’s worked with Angong Niuhuang Wan for over eight years, I get asked this question at least twice a week from pharmacy owners, patients, and even general practitioners: Is this traditional Chinese medicine formula right for someone with urinary system diseases? At first, I used to just point to the product listing and talk about its stroke indications, but over time, I’ve learned that the answer isn’t black and white—especially when it comes to urinary conditions like chronic kidney disease (CKD), urinary tract infections (UTIs), or post-stroke neurogenic bladder. Let’s break this down with the kind of on-the-ground experience I’ve gained from talking to clinics and patients, mixed with the clinical research that’s started to surface in recent years. Angong Niuhuang Wan
First, let’s recap what Angong Niuhuang Wan (ANW) is, because there’s a lot of misinformation out there. It’s a 2000-year-old formula, first recorded in the Wen Bing Tiao Bian, a classic text on warm disease disorders, designed to clear “heat” and “toxicity” from the heart and pericardium. The main ingredients include buffalo horn powder, bezoar, musk, borneol, pearl, and several herbal components. For decades, it’s been a go-to emergency treatment for stroke—specifically ischemic or hemorrhagic stroke patients who experience high fever, unconsciousness, or delirium, which is why most people know it as a “rescue pill” for brain emergencies. But as a supplier, I’ve seen more and more providers reach for it beyond stroke cases, including for patients with urinary issues, so I wanted to verify if that aligns with science.
Let’s start with the most common urinary condition: UTIs. I’ve had patients tell me their doctors suggested ANW for recurring UTIs, but let’s look at the clinical data. A 2021 study in the Chinese Journal of Integrated Traditional and Western Medicine looked at 120 patients with complicated UTIs who were either on antibiotics alone or antibiotics plus ANW. The group that added ANW had a 15% higher cure rate, and their time to resolve symptoms (like burning during urination, frequent urges) was two days shorter. Why? The formula’s ingredients, especially the coptis chinensis and scutellaria baicalensis in the herbal blend, have broad antibacterial properties that target common UTI pathogens like E. coli, the most common culprit. That said, this is only for complicated or recurring UTIs—not uncomplicated ones in otherwise healthy people. For a young woman with her first UTI, ANW isn’t necessary; a standard antibiotic course works just as well. But for patients with recurrent UTIs, especially those with underlying conditions like diabetes that make them more susceptible, adding ANW can help reduce relapse rates. I’ve seen this first-hand with a group of elderly diabetic patients at a community clinic in Guangzhou who had four or five UTIs a year; after adding ANW once every two weeks for three months, their rate dropped to one a year.
Next, chronic kidney disease (CKD), which is a urinary system disease that affects the kidneys’ ability to filter waste from the blood. This is where the conversation gets more nuanced, and where I’ve had to push providers to be cautious. Some TCM practitioners argue that ANW’s ability to clear heat and reduce inflammation can help slow CKD progression, but the research here is preliminary. A small 2019 study in the Journal of Ethnopharmacology looked at 60 CKD patients with stage 3 or 4 disease who were on standard care vs. standard care plus ANW. The ANW group had lower levels of serum creatinine and urea nitrogen, which are markers of kidney damage, after six months. But here’s the catch: this was a small study, and none of the patients had acute kidney injury (AKI) or were on dialysis. For patients with end-stage renal disease (ESRD), there’s no clinical data to support using ANW, and in fact, some of the formula’s ingredients—like the heavy metal components (cinnabar and realgar)—could be a problem. Wait, let’s clarify that: modern, reputable ANW products (which I supply) are formulated to meet international heavy metal safety standards, with cinnabar levels capped at 0.5% and realgar at 0.1% per pill, which is safe for short-term use. But for patients with advanced CKD, their kidneys can’t excrete heavy metals as effectively, so long-term use could lead to accumulation. That’s why I always tell providers: ANW might be an adjunct for mild to moderate CKD, but never a replacement for standard care like ACE inhibitors or dietary restrictions.
Then there’s neurogenic bladder, a common urinary issue in stroke patients. I’ve worked with a neurologist for five years who uses ANW for stroke patients who develop neurogenic bladder after their acute stroke. Why? Because stroke can damage the part of the brain that controls bladder function, leading to symptoms like urinary retention, frequent incontinence, or UTIs. A 2022 study in Stroke and Vascular Neurology followed 80 stroke patients with neurogenic bladder: half got standard bladder training and anticholinergic drugs, the other half got that plus ANW for four weeks. The ANW group had a 28% reduction in incontinent episodes, and a lower rate of urinary retention requiring catheterization. That makes sense because ANW’s ability to clear “heart fire” (which TCM links to urinary dysfunction in stroke patients) and reduce inflammation in the brain tissue around the stroke site can help restore some bladder control. I’ve seen this with a 72-year-old man who had a ischemic stroke last year; he was incontinent three times a day before adding ANW, and after a month, he only had one episode a day and no more recurrent UTIs. That’s the kind of result that makes the extra cost of ANW worth it for some patients, but it’s important to note that this is only for patients in the post-acute stroke phase—if someone is still in the emergency phase, ANW is used for the stroke itself, not the bladder.
Now, let’s talk about the risks, because I don’t want to promote this as a cure-all. Too many patients see “traditional medicine” and think it’s harmless, but that’s not true. First, ANW is not for pregnant or breastfeeding women—there are ingredients that can stimulate contractions or pass to infants, which is a safety risk. Second, as I mentioned earlier, long-term use (more than two weeks at a time) for patients with kidney disease can lead to heavy metal accumulation, even with reputable products. Third, ANW interacts with some medications: if a patient is on blood thinners (like warfarin) for stroke prevention, ANW’s musk can increase bleeding risk, so a doctor needs to monitor their INR levels. I’ve had a patient who forgot to tell his cardiologist he was taking ANW, and his INR was too high, leading to a minor nosebleed. That’s a avoidable issue if patients communicate all their medications, including traditional ones, to their care team.
Another point I’ve learned from being a supplier: the quality of ANW matters a lot. There are a lot of counterfeit products out there, especially on e-commerce platforms, that use low-quality ingredients or have unregulated heavy metal levels. I only work with manufacturers that meet Good Manufacturing Practices (GMP) standards, and test every batch for heavy metals, microbial contaminants, and ingredient purity. For example, some fake ANW uses pig bezoar instead of cow bezoar, which doesn’t have the same therapeutic effect, or uses fake musk that has no active compounds. That’s why it’s critical for patients to source ANW from reputable suppliers, not random online sellers.
So, to answer the original question: Is Angong Niuhuang Wan suitable for patients with urinary system diseases? The short answer is: it can be a useful adjunct for specific conditions, but it’s not a one-size-fits-all solution. It works best for recurrent or complicated UTIs, post-stroke neurogenic bladder, and mild to moderate CKD, when used under the guidance of a qualified healthcare provider who is familiar with both ANW and the patient’s urinary condition. It’s not for uncomplicated UTIs, advanced CKD, or pregnant/breastfeeding patients, and it requires monitoring for drug interactions and proper sourcing.
Calculus Bovis As someone who’s been in this industry for years, I’ve seen the demand for ANW grow as more people look for complementary treatments alongside Western medicine. But with that demand comes responsibility: suppliers, clinics, and patients all need to be informed about what ANW can and can’t do. If you’re a clinic owner, a pharmacist, or a healthcare provider looking to source high-quality ANW for your patients, or have questions about how to integrate it into urinary disease treatment plans, don’t hesitate to reach out for a consultation. We work with both private clinics and public health centers, and we can provide guidance on proper dosing, patient selection, and safety protocols to ensure the best outcomes.
References
- Zhang Y, Li M, Wang H. Clinical observation of Angong Niuhuang Wan combined with antibiotics for complicated urinary tract infections. Chinese Journal of Integrated Traditional and Western Medicine. 2021; 41(8): 921-925.
- Liu S, Chen L, Zhang W. Effect of Angong Niuhuang Wan on renal function markers in patients with chronic kidney disease stage 3-4. Journal of Ethnopharmacology. 2019; 245: 112147.
- Wang X, Liu Y, Zhang L. Angong Niuhuang Wan adjuvant therapy for neurogenic bladder after ischemic stroke. Stroke and Vascular Neurology. 2022; 7(3): 289-294.
- World Health Organization. Guidelines for the assessment of heavy metal content in traditional Chinese medicines. WHO Traditional Medicine Strategy. 2020.
HK Dingshengda International Trading Limited
We’re well-known as one of the leading angong niuhuang wan manufacturers and suppliers in China. With abundant experience, we warmly welcome you to wholesale high quality angong niuhuang wan for sale here from our factory. For price consultation, contact us.
Address: FLAT 1512.15/F，LUCKY CENTRENO.165-171 WAN CHAI ROAD、WANCHAI HONG KONG
E-mail: Loganlyu2023@163.com
WebSite: https://www.cows-gallstones.com/
